ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Mesenchymoma

Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingIrinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Muscle Cancer
2.RecruitingCombination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Muscle Cancer
3.RecruitingLiposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: adult soft tissue sarcoma
4.RecruitingCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
5.RecruitingSurgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act